150 related articles for article (PubMed ID: 15562429)
1. In vivo detection of microglial activation in frontotemporal dementia.
Cagnin A; Rossor M; Sampson EL; Mackinnon T; Banati RB
Ann Neurol; 2004 Dec; 56(6):894-7. PubMed ID: 15562429
[TBL] [Abstract][Full Text] [Related]
2. Depiction of microglial activation in aging and dementia: Positron emission tomography with [
Yokokura M; Terada T; Bunai T; Nakaizumi K; Takebayashi K; Iwata Y; Yoshikawa E; Futatsubashi M; Suzuki K; Mori N; Ouchi Y
J Cereb Blood Flow Metab; 2017 Mar; 37(3):877-889. PubMed ID: 27117856
[TBL] [Abstract][Full Text] [Related]
3. In-vivo measurement of activated microglia in dementia.
Cagnin A; Brooks DJ; Kennedy AM; Gunn RN; Myers R; Turkheimer FE; Jones T; Banati RB
Lancet; 2001 Aug; 358(9280):461-7. PubMed ID: 11513911
[TBL] [Abstract][Full Text] [Related]
4. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.
Venneti S; Wang G; Nguyen J; Wiley CA
J Neuropathol Exp Neurol; 2008 Oct; 67(10):1001-10. PubMed ID: 18800007
[TBL] [Abstract][Full Text] [Related]
5. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence for microglial activation in neurodegenerative dementia.
Cagnin A; Kassiou M; Meikle SR; Banati RB
Acta Neurol Scand Suppl; 2006; 185():107-14. PubMed ID: 16866919
[TBL] [Abstract][Full Text] [Related]
7. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.
Banati RB; Newcombe J; Gunn RN; Cagnin A; Turkheimer F; Heppner F; Price G; Wegner F; Giovannoni G; Miller DH; Perkin GD; Smith T; Hewson AK; Bydder G; Kreutzberg GW; Jones T; Cuzner ML; Myers R
Brain; 2000 Nov; 123 ( Pt 11)():2321-37. PubMed ID: 11050032
[TBL] [Abstract][Full Text] [Related]
8. PK ('peripheral benzodiazepine')--binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia.
Banati RB; Myers R; Kreutzberg GW
J Neurocytol; 1997 Feb; 26(2):77-82. PubMed ID: 9181482
[TBL] [Abstract][Full Text] [Related]
9. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
10. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.
Venneti S; Wagner AK; Wang G; Slagel SL; Chen X; Lopresti BJ; Mathis CA; Wiley CA
Exp Neurol; 2007 Sep; 207(1):118-27. PubMed ID: 17658516
[TBL] [Abstract][Full Text] [Related]
11. Microglial activation in healthy aging.
Schuitemaker A; van der Doef TF; Boellaard R; van der Flier WM; Yaqub M; Windhorst AD; Barkhof F; Jonker C; Kloet RW; Lammertsma AA; Scheltens P; van Berckel BN
Neurobiol Aging; 2012 Jun; 33(6):1067-72. PubMed ID: 21051106
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain.
Pedersen MD; Minuzzi L; Wirenfeldt M; Meldgaard M; Slidsborg C; Cumming P; Finsen B
Eur J Neurosci; 2006 Aug; 24(4):991-1000. PubMed ID: 16930426
[TBL] [Abstract][Full Text] [Related]
13. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration.
Gerhard A; Watts J; Trender-Gerhard I; Turkheimer F; Banati RB; Bhatia K; Brooks DJ
Mov Disord; 2004 Oct; 19(10):1221-6. PubMed ID: 15390000
[TBL] [Abstract][Full Text] [Related]
14. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.
Snowden JS; Thompson JC; Stopford CL; Richardson AM; Gerhard A; Neary D; Mann DM
Brain; 2011 Sep; 134(Pt 9):2478-92. PubMed ID: 21840888
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.
Gerhard A; Pavese N; Hotton G; Turkheimer F; Es M; Hammers A; Eggert K; Oertel W; Banati RB; Brooks DJ
Neurobiol Dis; 2006 Feb; 21(2):404-12. PubMed ID: 16182554
[TBL] [Abstract][Full Text] [Related]
16. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion.
Cagnin A; Myers R; Gunn RN; Lawrence AD; Stevens T; Kreutzberg GW; Jones T; Banati RB
Brain; 2001 Oct; 124(Pt 10):2014-27. PubMed ID: 11571219
[TBL] [Abstract][Full Text] [Related]
17. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study.
Turner MR; Cagnin A; Turkheimer FE; Miller CC; Shaw CE; Brooks DJ; Leigh PN; Banati RB
Neurobiol Dis; 2004 Apr; 15(3):601-9. PubMed ID: 15056468
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria in activated microglia in vitro.
Banati RB; Egensperger R; Maassen A; Hager G; Kreutzberg GW; Graeber MB
J Neurocytol; 2004 Sep; 33(5):535-41. PubMed ID: 15906160
[TBL] [Abstract][Full Text] [Related]
19. Visualising microglial activation in vivo.
Banati RB
Glia; 2002 Nov; 40(2):206-217. PubMed ID: 12379908
[TBL] [Abstract][Full Text] [Related]
20. Microglial activation and dopamine terminal loss in early Parkinson's disease.
Ouchi Y; Yoshikawa E; Sekine Y; Futatsubashi M; Kanno T; Ogusu T; Torizuka T
Ann Neurol; 2005 Feb; 57(2):168-75. PubMed ID: 15668962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
